AI Article Synopsis

  • - Human herpesvirus-8 (HHV-8), linked to Kaposi's sarcoma (KS), is more prevalent in individuals co-infected with HIV-1, especially in sub-Saharan African men, making it common among this group prior to the HIV-1 epidemic.
  • - Researchers tested 58 HHV-8-positive serum samples for antibodies targeting specific glycoproteins and found that neutralizing capacity increases during KS remission, with heightened antibodies against glycoprotein K8.1 during both active disease and remission.
  • - The study suggests that glycoproteins like gHgL could be key targets for neutralizing antibodies, and recovery from KS might be linked to enhanced neutralizing capacity, indicating a

Article Abstract

Human herpesvirus-8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus, is a human oncogenic herpesvirus that is responsible for several diseases including Kaposi's sarcoma (KS). KS prevalence varies dramatically, although emergence increases considerably with human immunodeficiency virus -1 (HIV-1) co-infection, making it one of the most common cancers in HIV-1 patients and sub-Saharan African men, even prior to the HIV-1 epidemic in Africa. Studies have shown that neutralizing antibodies exist in HHV-8-infected sera, which are most likely targeted to viral lytic surface glycoproteins, such as glycoprotein K8.1 (gpK8.1) and gHgL. Fifty-eight HHV-8-positive serum samples were tested for the levels of gpK8.1- and gHgL-binding antibodies and HHV-8-neutralizing capacity. Each sample was then categorized according to the disease status, which included asymptomatic infection, active KS and remission from KS, and the three measured parameters were compared between the disease groups. We show that neutralizing capacity in infected patient sera increases with remission of KS. Interestingly, antibodies targeting gpK8.1, but not gHgL, were also found to be increased during active disease and remission. Comparison of neutralizing capacity and antibody levels on an individual patient basis revealed that antibody levels, primarily targeting gHgL, are correlated with serum neutralizing response in sub-lingual Kaposi sarcoma (SLK) cells. Adsorption of gHgL or gpK8.1 antibodies from human sera removed the neutralizing response in SLK cells, although some non-specific removal of antibodies from the sera means that this result should be interpreted with caution. Taken collectively, these results suggest that glycoproteins, such as gHgL, are targets for neutralizing antibodies. Furthermore, our data imply that recovery from KS is associated with increased neutralizing capacity, suggesting that neutralizing antibodies may contribute to KS resolution. However, it is vital for further work to be completed in order to elucidate this relationship.

Download full-text PDF

Source
http://dx.doi.org/10.1099/jgv.0.002044DOI Listing

Publication Analysis

Top Keywords

neutralizing response
12
neutralizing antibodies
12
neutralizing capacity
12
neutralizing
9
human herpesvirus-8
8
kaposi's sarcoma
8
gpk81 ghgl
8
antibody levels
8
slk cells
8
antibodies
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!